Trials / Completed
CompletedNCT04343404
Place of ECMO in the Management of Severe Refractory ARDS Associated With Covid-19
STUDY ECMO-COVID-19 : Place of ECMO in the Management of Severe Refractory ARDS Associated With Covid-19
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (actual)
- Sponsor
- University Hospital, Strasbourg, France · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- —
Summary
Describe COVID-19 patients who are receiving ECMO-VV respiratory replacement and what happens to them.
Conditions
Timeline
- Start date
- 2020-04-01
- Primary completion
- 2020-04-15
- Completion
- 2020-04-15
- First posted
- 2020-04-13
- Last updated
- 2020-06-29
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT04343404. Inclusion in this directory is not an endorsement.